Bos taurus gallstone

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Bos taurus gallstone
DrugBank Accession Number
DB14248
Background

Bos taurus gallstone is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.

Type
Biotech
Groups
Experimental
Synonyms
  • Artificial Cow-bezoan
  • Aurochs Gallstone
  • Bezoar
  • Bos Indicus Gallstone
  • Bos Primigenius Gallstone
  • Bos Taurus Gallstone Preparation
  • Bovine Gallstone
  • Bovis Calculus
  • Bovis Calculus Artifactus
  • Bovis Calculus Sativus
  • Calculus Bovis
  • Cow Gallstone
  • Cow-bezoan Cultured in Vitro
  • Cow-bezoar
  • Domestic Cattle Gallstone
  • Domestic Cow Gallstone
  • Niu Huang
  • Niuhuang
  • Rengong Niuhuang
  • Tiwai Peiyu Niuhuang

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Ma Ying Long HemorrhoidalBos taurus gallstone (0.1 g/10g) + Amber (0.1 g/10g) + Borneol (0.2 g/10g) + Moschus berezovskii musk sac resin (0.15 g/10g) + Pearl (hyriopsis cumingii) (0.25 g/10g) + Sodium borate decahydrate (0.2 g/10g) + Zinc carbonate (0.65 g/10g)OintmentTopicalTRIFECTA PHARMACEUTICALS USA LLC2016-01-14Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Ma Ying Long HemorrhoidalBos taurus gallstone (0.1 g/10g) + Amber (0.1 g/10g) + Borneol (0.2 g/10g) + Moschus berezovskii musk sac resin (0.15 g/10g) + Pearl (hyriopsis cumingii) (0.25 g/10g) + Sodium borate decahydrate (0.2 g/10g) + Zinc carbonate (0.65 g/10g)OintmentTopicalTRIFECTA PHARMACEUTICALS USA LLC2016-01-14Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
4162LZ0N4O
CAS number
Not Available

References

General References
Not Available
RxNav
1737793

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
Not AvailableNot Yet RecruitingTreatmentAuto-immune Encephalitis / Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody / Encephalitis / Viral Encephalitis1somestatusstop reasonjust information to hide
Not AvailableRecruitingTreatmentAcute Disseminated Encephalomyelitis / Idiopathic Inflammatory Demyelinating Disease / Multiple Sclerosis / Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD) / Neuromyelitis Optica Spectrum Disorders1somestatusstop reasonjust information to hide
Not AvailableRecruitingTreatmentAcute Ischemic Stroke / Cerebral Small Vessels Disease / Ischemic Cerebrovascular Disease1somestatusstop reasonjust information to hide
3CompletedTreatmentAcute Ischemic Stroke1somestatusstop reasonjust information to hide
2, 3Unknown StatusPreventionStroke (CVA) or TIA1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
OintmentTopical
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at July 05, 2018 17:13 / Updated at June 12, 2020 16:53